Retatrutide

Batch & Supply Format

• ≥99% purity verified by independent third-party HPLC/MS
• Lyophilized peptide format (research vials)
• Singles and 10-packs available
• COA transparency: posted on-page for the active lot
• U.S. domestic fulfillment with appropriate packing

---

 

What Is Retatrutide (LY3437943)?

Retatrutide (LY3437943) is a synthetic triple-agonist peptide studied in metabolic and receptor-signaling research models for simultaneous activity at:

1. GLP-1 receptor — incretin-pathway signaling models
2. GIP receptor — complementary incretin signaling research
3. Glucagon receptor — energy-balance and lipid signaling models

Supplied for in-vitro/ex-vivo research by qualified laboratories; not for administration to humans or animals.

---

 

Mechanistic Overview

• GLP-1 axis: receptor-mediated signaling models and glucose dynamics research
• GIP axis: glucose-dependent signaling pathways and incretin synergy research
• Glucagon axis: lipid mobilization and energy-expenditure pathway modeling

---

 

Research Evidence Snapshot

Published preclinical and Phase 2 literature describes metabolic endpoints associated with triple-agonist peptides compared to single- and dual-agonist incretin approaches. Researchers should review primary sources for protocol design, model selection, and methodological details applicable to their work.